Opioid Peptides and Serotonin Regulate Gut Relaxation Through Non-Standard Nerve Pathways
Opioid peptides (acting through mu, delta, and kappa receptors) and serotonin modulate the non-adrenergic, non-cholinergic nerve pathways that control intestinal relaxation in the rat duodenum.
Quick Facts
What This Study Found
Opioid peptides acting through all three receptor types (mu, delta, kappa) enhance non-adrenergic non-cholinergic inhibitory responses in the duodenum, while serotonin reduces them.
Key Numbers
How They Did This
In vitro experiments using isolated rat duodenal segments with electrical field stimulation in the presence of atropine and guanethidine (to block standard pathways). Dose-response curves were generated for opioid agonists (DAGO, DPDPE, dynorphin) and serotonin.
Why This Research Matters
Understanding how opioid peptides regulate gut motility helps explain both the constipating effects of opioid drugs and the potential role of endogenous opioid peptides in gut function disorders.
The Bigger Picture
This research contributed to understanding the gut's complex nerve regulation system, relevant to conditions like irritable bowel syndrome where non-standard nerve pathways and serotonin both play key roles.
What This Study Doesn't Tell Us
In vitro study using isolated rat gut tissue. Results may not directly translate to intact gut physiology or human intestinal function.
Questions This Raises
- ?Could selective opioid receptor agonists be used to treat gut motility disorders without the side effects of traditional opioids?
- ?How do endogenous opioid peptide levels in the gut change in conditions like IBS?
Trust & Context
- Key Stat:
- All 3 opioid receptor types active Mu, delta, and kappa opioid agonists all produced dose-dependent increases in gut relaxation, reversed by naloxone
- Evidence Grade:
- Preliminary in vitro evidence from isolated rat tissue. Well-controlled pharmacological study but limited physiological relevance.
- Study Age:
- Published in 1993, this study contributed to the early understanding of opioid peptide roles in gut physiology.
- Original Title:
- Modulation of non-adrenergic non-cholinergic inhibitory transmission in rat duodenum: role of opiates and 5-hydroxytryptamine.
- Published In:
- Archives italiennes de biologie, 131(2-3), 235-43 (1993)
- Authors:
- Postorino, A, Serio, R, Mulè, F, Adamo, E B, Di Giovanni, G, Marini, R
- Database ID:
- RPEP-00271
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What are non-adrenergic non-cholinergic nerves?
These are nerve pathways in the gut that operate independently of adrenaline (adrenergic) and acetylcholine (cholinergic) — the two main nervous system signaling molecules. They use other neurotransmitters including nitric oxide and peptides to regulate gut motility.
Why do opioids cause constipation?
This study helps explain the mechanism: opioid peptides enhance inhibitory (relaxation) responses in the gut through non-standard nerve pathways. When opioid drugs overstimulate these pathways, gut motility slows down, leading to constipation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00271APA
Postorino, A; Serio, R; Mulè, F; Adamo, E B; Di Giovanni, G; Marini, R. (1993). Modulation of non-adrenergic non-cholinergic inhibitory transmission in rat duodenum: role of opiates and 5-hydroxytryptamine.. Archives italiennes de biologie, 131(2-3), 235-43.
MLA
Postorino, A, et al. "Modulation of non-adrenergic non-cholinergic inhibitory transmission in rat duodenum: role of opiates and 5-hydroxytryptamine.." Archives italiennes de biologie, 1993.
RethinkPeptides
RethinkPeptides Research Database. "Modulation of non-adrenergic non-cholinergic inhibitory tran..." RPEP-00271. Retrieved from https://rethinkpeptides.com/research/postorino-1993-modulation-of-nonadrenergic-noncholinergic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.